Chardan Healthcare Acquisition Corp. (CHAC) financial statements (2020 and earlier)

Company profile

Business Address 17 STATE STREET, 16TH FLOOR
NEW YORK, NY 10004
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
6/30/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments821
Cash and cash equivalents721
Short-term investments10 
Restricted cash and investments0 
Receivables0 
Prepaid expense 0
Other current assets2 
Total current assets:851
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment2 
Long-term investments and receivables 71
Long-term investments 71
Deposits noncurrent assets0 
Other undisclosed noncurrent assets50
Total noncurrent assets:871
TOTAL ASSETS:9272
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities30
Accounts payable3 
Taxes payable 0
Debt0 
Other liabilities3 
Other undisclosed current liabilities 0
Total current liabilities:60
Noncurrent Liabilities
Long-term debt and lease obligation, including:1 
Other undisclosed long-term debt and lease obligation1 
Liabilities, other than long-term debt11
Due to related parties 1
Business combination, contingent consideration, liability1 
Total noncurrent liabilities:11
Total liabilities:81
Temporary equity, carrying amount 66
Stockholders' equity
Stockholders' equity attributable to parent845
Common stock00
Additional paid in capital1275
Accumulated other comprehensive loss(42) 
Retained earnings 0
Total stockholders' equity:845
TOTAL LIABILITIES AND EQUITY:9272

Income statement (P&L) ($ in millions)

12/31/2019
6/30/2019
Gross profit:1 
Operating expenses(22)(0)
Other undisclosed operating loss(1) 
Operating loss:(22)(0)
Nonoperating income
(Investment Income, Nonoperating)
2 
Other undisclosed income from continuing operations before equity method investments, income taxes 1
Income (loss) from continuing operations before income taxes:(21)0
Income tax expense(2)(0)
Income (loss) before gain (loss) on sale of properties:(23)0
Other undisclosed net income2 
Net income (loss) attributable to parent:(21)0
Other undisclosed net income available to common stockholders, basic41 
Net income available to common stockholders, diluted:210

Comprehensive Income ($ in millions)

12/31/2019
6/30/2019
Net income (loss):(21)0
Comprehensive income (loss), net of tax, attributable to parent:(21)0

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: